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INTRODUCTION:  Basaloid  squamous  cell  carcinoma  of the esophagus  (BSCE)  is a rare  malignancy  among
esophageal  cancers.  We  reported  a case  of  63-year-old  woman  with  metachronous  pulmonary  metastasis
of  BSCE,  successfully  treated  by  metastasectomy  of the left  lung.
PRESENTATION OF  CASE:  Biopsy  specimens  of  upper  gastrointestinal  ﬁberscopy  led  to diagnosis  of  poorly
differentiated  squamous  cell  carcinoma  of the  esophagus.  Computed  tomography  revealed  metastatic
lymph  nodes  surrounding  the  bilateral  recurrent  laryngeal  nerve  and  no  evidence  of  metastasis  to  dis-
tant  organs.  Curative  esophagectomy  with  three-ﬁeld  lymph  node  dissection  was  performed  through
thoracoscopic  approach.  Pathological  examination  of  the  resected  specimens  led  to  diagnosis  of BSCE
with  invasion  into  the  submucosal  layer  of  the  esophageal  wall.  Two  years  later,  a solitary  oval-shaped
pulmonary  lesion  of approximately  10 mm  was  detected  in  the  left  lung.  Wedge  resection  of  the  left
upper  lobe  was  performed  via  thoracoscopic  approach.  The  postoperative  course  was uneventful.  Histo-
logically,  the  pulmonary  lesion  was  diagnosed  as  metastatic  BSCE.  Follow-up  indicated  no  recurrence  9
years  after  the  initial  surgery.
DISCUSSION: Surgical  intervention  was  acceptable  on this  case  of solitary  pulmonary  metastasis.  How-
ever,  data  are  lacking  about  the  efﬁcacy  of  pulmonary  resection  for  metachronous  pulmonary  metastasis
of  BSCE  because  the  postoperative  outcome  is  usually  poor.  The  efﬁcacy  of surgical  intervention  for
metastatic  lesions  of  BSCE  is  debatable  and  requires  further  examination.
CONCLUSION: Although  the  usefulness  of surgical  intervention  for  metastatic  lesions  from  BSCE  is  con-
troversial,  the  patients  with  metachronous  solitary  metastasis  to  the  lung  and without  extrapulmonary
metastasis  would  be good  candidate  for  pulmonary  resection.
© 2012 Surgical Associates Ltd. Published by Elsevier Ltd. Open access under CC BY-NC-ND license.. Introduction
In Japan, squamous cell carcinoma is most common type of
sophageal cancer.1 Basaloid squamous cell carcinoma of the
sophagus (BSCE) is an uncommon variant of squamous cell car-
inoma of the esophagus (SCCE), and is extremely rare among
sophageal malignancies. BSCE comprises approximately 0.1% of
he esophageal carcinomas.1 It is associated with a poor outcome
fter surgery because of its high proliferative activity, and high inci-
ence of distant metastasis.2,3 Many reports have described the
rognosis of BSCE as worse than that of SCCE.2,4,5 In this report, we
escribed a case of long-term survival after successful treatment
ith pulmonary resection for metachronous pulmonary metastasis
f BSCE.
∗ Corresponding author. Tel.: +81 798 45 6372; fax: +81 798 45 6373.
E-mail  address: mtake@hyo-med.ac.jp (M.  Takemura).
1 Tel.: +81 6 6929 1221; fax: +81 6 6929 0886.
210-2612 ©  2012 Surgical Associates Ltd. Published by Elsevier Ltd. 
ttp://dx.doi.org/10.1016/j.ijscr.2012.05.013
Open access under CC2. Presentation of case
A 63-year-old woman, with a history of dysphagia for 4 months,
was diagnosed with BSCE in the form of an elevated lesion of
the lower thoracic esophagus by upper gastrointestinal ﬁberscopy
(Fig. 1). Barium swallow showed an irregular shadow on the left
side of the lower thoracic esophagus. Histological evaluation of
biopsy specimens indicated poorly differentiated SCCE. Computed
tomography (CT) revealed wall thickening in the lower thoracic
esophagus, but no evidence of invasion to adjacent structures
or metastasis to distant organs. Metastatic lymph nodes were
detected in the surrounding bilateral recurrent laryngeal nerve.
Curative esophagectomy with three-ﬁeld lymph node dissection
was performed via a thoracoscopic approach. A gastric tube was
made by laparoscopic approach and used for esophageal substi-
tute through postmediastinal route. Postoperatively, left recurrent
laryngeal nerve palsy was  observed.
Macroscopically, the resected specimen was  an elevated lesion
of the lower thoracic esophagus, measuring 3.0 cm × 2.0 cm (Fig. 2).
Histologically, the cancer cells, which were similar to esophageal
 BY-NC-ND license.
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Fig. 1. Preoperative upper gastrointestinal ﬁberscopy showed an elevated lesion in
the lower thoracic esophagus. Histological examination of biopsy specimens from
t
e
b
w
i
o
c
h
t
T
4
a
c
c
s
a
t
l
p
e
w
w
c
d
F
g
Fig. 3. Cancer cells, similar to basal cells of the esophagus, invading into the sub-
mucosal  layer of the esophageal wall. No evidence of lymphatic or venous invasion
was  observed. Cancer nests of basaloid cells in a lobular conﬁguration and massive
submucosal expansion are visible.his lesion were diagnosed as poorly differentiated squamous cell carcinoma of the
sophagus.
asal cells, had invaded into the submucosal layer of the esophageal
all, but no lymphatic or venous invasion was detected. The prox-
mal and distal margins were cancer-free. Nests of basaloid cells
f various sizes in a lobular conﬁguration showed massive submu-
osal expansion (Fig. 3). Scant cytoplasm, round to oval nuclei and a
igh nuclear to cytoplasmic ratio were compatible with BSCE. Soli-
ary lymph node metastasis was detected in the paragastric node.
he patient was discharged from our hospital on postoperative day
2.
Two years later, a solitary oval-shaped pulmonary lesion of
pproximately 10 mm in size was detected in the left lung on
hest CT (Fig. 4). Tumor markers including the SCC antigen and
arcinoembryonic antigens were within normal limits. Although
ystemic chemotherapy with combined with 5-ﬂuorouracil (5-FU)
nd cisplatin (CDDP) was  offered initially, the patient rejected
his treatment. Wedge resection of the upper lobe of the left
ung was therefore performed via thoracoscopic approach. No
leural dissemination was observed intraoperatively. The postop-
rative course was uneventful. Histologically, the pulmonary lesion
as diagnosed as metastatic BSCE (Fig. 5). No adjuvant therapy
as administered after pulmonary resection. The patient was  dis-
harged from our hospital on postoperative day 10. The patient is
oing well without any recurrence 9 years after ﬁrst operation.
ig. 2. The resected specimen was an elevated lesion of the lower thoracic esopha-
us,  measuring 3.0 cm × 2.0 cm.
Fig. 4. Chest computed tomography 2 years postoperatively showed a solitary oval
pulmonary lesion of approximately 10 mm in the left lung.
Fig. 5. Histological evaluation of the pulmonary lesion led to diagnosis of metastasis
of  basaloid squamous cell carcinoma of the esophagus.
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. Discussion
In Japan, many cases of esophageal cancer are diagnosed as squa-
ous cell carcinoma; other types of malignancies are rare.1 BSCE
as been thought to comprise approximately 0.1% of all esophageal
arcinomas, according to a comprehensive registry of esophageal
ancers in Japan.1 However, considering recent advancements in
he histological recognition of this type of tumor, the true incidence
f BSCE is still uncertain.6,4 Upper gastrointestinal ﬁberscopy with
iopsy is the most commonly used method of diagnosis for the
sophageal cancer prior to treatment. On endoscopic examination,
SCE is characterized as a protruding or submucosal tumor-like
esion, and the tumor was covered with normal mucosa at super-
cial type.7 Therefore, BSCE is difﬁcult to diagnose by biopsy. The
ate of correct preoperative diagnosis of BSCE has been reported to
e <10%.5
The prognosis of BSCE has been reported as worse compared to
hat of SCCE, because of its high incidence of distant metastasis.3,8
aito et al. suggested that higher levels of cyclin D1 and lower
xpression of E-cadherin in BSCE than those in SCCE may  correlate
ith high biological malignancy and a poor prognosis in patients
ith BSCE.9 On the other hand, Chen reported that the progno-
is of BSCE was signiﬁcantly poorer than that of well-differentiated
CCE, but was similar to that of moderately or poorly differentiated
CCE.5
Standard treatment for BSCE has not yet been established,
ecause of its low incidence. At present, the treatment options
or BSCE are similar to those for typical SCCE, because of the
ifﬁculties of correct pretreatment diagnosis.9 The beneﬁts and
sefulness of combined chemotherapy using 5-FU and CDDP for
CCE have been well documented.10 However, the efﬁcacy of
his combined therapy has not been investigated in BSCE. Koide
t al.11 reported two cases of BSCE of the esophagus treated by
reoperative chemotherapy using 5-FU and CDDP. Follow-up in
ne case indicated no recurrence 38 months after chemother-
py. Shibata et al.12 reported a case of recurrent BSCE successfully
reated by combination chemotherapy using 5-FU and CDDP. These
eports suggested usefulness of combination chemotherapy for
SCE. On the other hand, in an analysis of the activities of the 5-FU
elated enzymes, such as thymidylate synthase (TS), dihydropyrim-
dine dehydrogenase (DPD) and orotate phosphoribosyl transferase
OPRT), in esophageal cancer tissue, the TS activity in BSCE was sig-
iﬁcantly higher than that in SCCE.13 However, no difference in
PD or OPRT was observed between these types of tumor. These
esults suggested that BSCE is more resistance to 5-FU than in SCCE.
ecause BSCE is a rare malignancy among esophageal carcinoma,
omparison of the efﬁciency of chemotherapy regimens between
SCE and SCCE is difﬁcult. Studies of a large sample are required
o establish the role of combination chemotherapy in treatment of
SCE.
Esophageal cancer is known to be a lethal disease. Even after
xtended radical esophagectomy with three-ﬁeld lymph node
issection, 40–50% of patients develop recurrent disease.14,15
ecurrent disease after esophagectomy may  be locoregional
nd/or hematogenous. Common sites of hematogenous recurrence
nclude lung, liver and bone. Nakagawa et al.16 reported shorter
isease-free intervals and median survival time in patients with
ematogenous recurrence than in patients with locoregional recur-
ence. Nonsurgical treatments, such as systemic chemotherapy,
re usually indicated for patients with hematogenous recurrence
ecause it is widely regarded as a systemic disease. However, some
eports have described the beneﬁts of surgical treatment for pul-
onary metastasis from esophageal cancer.17,18 In these reports,
atients with solitary pulmonary metastasis and no extrapul-
onary metastasis were good candidates for pulmonary resection.
n the case reported here, solitary pulmonary metastasis was
1PEN  ACCESS
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detected  and the patient’s systemic condition was stable enough
to withstand surgical intervention. However, data are lacking about
the efﬁcacy of pulmonary resection for metachronous pulmonary
metastasis of BSCE because the postoperative outcome is usually
poor. The efﬁcacy of surgical intervention for metastatic lesions of
BSCE is debatable and requires further examination.
4. Conclusions
We  reported the case of a 63-year-old female with BSCE in
whom solitary metachronous pulmonary metastasis was  diag-
nosed 2 years after esophagectomy. In this case, the metastatic
lesion was  successfully treated by surgical intervention. However,
examination of more cases is required to ascertain the role of pul-
monary resection in treatment of pulmonary metastasis of BSCE,
because the incidence of this disease is low and no standard treat-
ment options have been established.
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